Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.

Source:http://linkedlifedata.com/resource/pubmed/id/9392308

Transplantation 1997 Nov 27 64 10 1438-42

Download in:

View as

General Info

PMID
9392308